St. Jude Medical Resolves FDA Warning Letter for Plano Facility

Wed, 08/27/2014 - 9:22am
The Associated Press

St. Jude Medical, Inc., a global medical device company, has announced that it has been notified by the U.S. Food and Drug Administration (FDA) that issues cited in the Plano, Texas, facility’s warning letter have been addressed.

“We’re pleased to have resolved the concerns identified by the FDA at our Plano manufacturing facility," said Daniel J. Starks, chairman, president and chief executive officer at St. Jude Medical. “We take quality and compliance seriously and are committed to meeting and exceeding patient, physician and regulator expectations in these areas.”


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.